Drugs / ACAM1000
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00053508 | Sep 2002 → Mar 2003 | smallpox | Sanofi Pasteur, a Sanofi Company | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACAM1000 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00053508 ↗ |
| Modality | Vaccine | “ACAM1000 Smallpox Vaccine” NCT00053508 ↗ |